Jiangxi Bossen Pharm-Tech Co., Ltd. was established at 1st, July, 2014. The company is located in Jinxi Spice Industrial Park Zone C, which is named as "China incense Capital", covering an area of 120 mu, invested and founded by merchants from Taizhou, Zhejiang, with a registered capital of 50 million yuan. Our company is a chemical and pharmaceutical enterprise engaged in the production of new medicine and intermediates. The company has invested 200 million yuan in fixed assets. In 2019, the company became a high-tech and small and medium-sized technology enterprise. In 2020, the company completed output value of more than 50 million yuan. In 2021, the output value is more than 80 million yuan.
Our product development strategy is to produce quinolone antibacterial and anti-inflammatory pharmaceutical intermediates, and gradually to increase the latest liptin diabetes and anti-tumor, hypertension pharmaceutical intermediates. The company plans to spend 2-3 years to build and improve the pharmaceutical intermediates project; In the next 3-5 years, the company will gradually build GMP fine drying and packaging projects mainly based on API; In the next 5-10 years, the enterprise will gradually develop into finished drug projects on the basis of manufacturing bulk drugs.
In order to meet the company's product development and related management and technical personnel reserve, we cooperate with well-known domestic universities to carry out project research and development.
